<!DOCTYPE html>
<html lang="en" dir="auto">

<head>
<head>
    <title>sexual and reproductive health</title>
    <meta charset="utf-8">
    <meta name="description"
        content="Website meta description for google search results go here" />
    <meta name="dc.relation" content="https://trxiv.yorks0n.com" />
    <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
    <meta name="theme-color" content="#1A94D2" />

    

    
    
    
    <link rel="stylesheet" href="/css/main.min.css" media="screen">

</head>


<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<meta name="robots" content="index, follow">
<title>sexual and reproductive health | TRxiv2</title>
<meta name="keywords" content="">
<meta name="description" content="The Zipime-Weka-Schista study protocol: a longitudinal cohort study and economic evaluation of an integrated home-based approach for genital multi-pathogen screening in women, including female genital schistosomiasis, HPV, Trichomonas and HIV in Zambia
Authors: Shanaube, K.; Ndubani, R.; Kelly, H.; Webb, E.; Mayaud, P.; Lamberti, O.; Fitzpatrick, J.; Kasese, N.; Sturt, A.; Van Lieshout, L.; Van Dam, G.; Corstjens, P. L. A. M.; Kosloff, B.; Bond, V.; Hayes, R.; Terris-Prestholt, F.">
<meta name="author" content="">
<link rel="canonical" href="https://trxiv.yorks0n.com/posts/sexual-and-reproductive-health/">
<link crossorigin="anonymous" href="/assets/css/stylesheet.904bd1e751cdd2a584fa6bed3fa1166dfd8ec9949ebfd0c4d69c5add5e17c23d.css" integrity="sha256-kEvR51HN0qWE&#43;mvtP6EWbf2OyZSev9DE1pxa3V4Xwj0=" rel="preload stylesheet" as="style">
<script defer crossorigin="anonymous" src="/assets/js/highlight.f413e19d0714851f6474e7ee9632408e58ac146fbdbe62747134bea2fa3415e0.js" integrity="sha256-9BPhnQcUhR9kdOfuljJAjlisFG&#43;9vmJ0cTS&#43;ovo0FeA="
    onload="hljs.initHighlightingOnLoad();"></script>
<link rel="icon" href="https://trxiv.yorks0n.com/favicon.ico">
<link rel="icon" type="image/png" sizes="16x16" href="https://trxiv.yorks0n.com/favicon-16x16.png">
<link rel="icon" type="image/png" sizes="32x32" href="https://trxiv.yorks0n.com/favicon-32x32.png">
<link rel="apple-touch-icon" href="https://trxiv.yorks0n.com/apple-touch-icon.png">
<link rel="mask-icon" href="https://trxiv.yorks0n.com/safari-pinned-tab.svg">
<meta name="theme-color" content="#2e2e33">
<meta name="msapplication-TileColor" content="#2e2e33">
<noscript>
    <style>
        #theme-toggle,
        .top-link {
            display: none;
        }

    </style>
    <style>
        @media (prefers-color-scheme: dark) {
            :root {
                --theme: rgb(29, 30, 32);
                --entry: rgb(46, 46, 51);
                --primary: rgb(218, 218, 219);
                --secondary: rgb(155, 156, 157);
                --tertiary: rgb(65, 66, 68);
                --content: rgb(196, 196, 197);
                --hljs-bg: rgb(46, 46, 51);
                --code-bg: rgb(55, 56, 62);
                --border: rgb(51, 51, 51);
            }

            .list {
                background: var(--theme);
            }

            .list:not(.dark)::-webkit-scrollbar-track {
                background: 0 0;
            }

            .list:not(.dark)::-webkit-scrollbar-thumb {
                border-color: var(--theme);
            }
        }

    </style>
</noscript><meta property="og:title" content="sexual and reproductive health" />
<meta property="og:description" content="The Zipime-Weka-Schista study protocol: a longitudinal cohort study and economic evaluation of an integrated home-based approach for genital multi-pathogen screening in women, including female genital schistosomiasis, HPV, Trichomonas and HIV in Zambia
Authors: Shanaube, K.; Ndubani, R.; Kelly, H.; Webb, E.; Mayaud, P.; Lamberti, O.; Fitzpatrick, J.; Kasese, N.; Sturt, A.; Van Lieshout, L.; Van Dam, G.; Corstjens, P. L. A. M.; Kosloff, B.; Bond, V.; Hayes, R.; Terris-Prestholt, F." />
<meta property="og:type" content="article" />
<meta property="og:url" content="https://trxiv.yorks0n.com/posts/sexual-and-reproductive-health/" /><meta property="article:section" content="posts" />
<meta property="article:published_time" content="2023-10-11T10:39:46+00:00" />
<meta property="article:modified_time" content="2023-10-11T10:39:46+00:00" />

<meta name="twitter:card" content="summary"/>
<meta name="twitter:title" content="sexual and reproductive health"/>
<meta name="twitter:description" content="The Zipime-Weka-Schista study protocol: a longitudinal cohort study and economic evaluation of an integrated home-based approach for genital multi-pathogen screening in women, including female genital schistosomiasis, HPV, Trichomonas and HIV in Zambia
Authors: Shanaube, K.; Ndubani, R.; Kelly, H.; Webb, E.; Mayaud, P.; Lamberti, O.; Fitzpatrick, J.; Kasese, N.; Sturt, A.; Van Lieshout, L.; Van Dam, G.; Corstjens, P. L. A. M.; Kosloff, B.; Bond, V.; Hayes, R.; Terris-Prestholt, F."/>


<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BreadcrumbList",
  "itemListElement": [, 
    {
      "@type": "ListItem",
      "position":  2 ,
      "name": "Posts",
      "item": "https://trxiv.yorks0n.com/posts/"
    }, 
    {
      "@type": "ListItem",
      "position":  3 ,
      "name": "sexual and reproductive health",
      "item": "https://trxiv.yorks0n.com/posts/sexual-and-reproductive-health/"
    }
  ]
}
</script>
<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BlogPosting",
  "headline": "sexual and reproductive health",
  "name": "sexual and reproductive health",
  "description": "The Zipime-Weka-Schista study protocol: a longitudinal cohort study and economic evaluation of an integrated home-based approach for genital multi-pathogen screening in women, including female genital schistosomiasis, HPV, Trichomonas and HIV in Zambia\nAuthors: Shanaube, K.; Ndubani, R.; Kelly, H.; Webb, E.; Mayaud, P.; Lamberti, O.; Fitzpatrick, J.; Kasese, N.; Sturt, A.; Van Lieshout, L.; Van Dam, G.; Corstjens, P. L. A. M.; Kosloff, B.; Bond, V.; Hayes, R.; Terris-Prestholt, F.",
  "keywords": [
    
  ],
  "articleBody": " The Zipime-Weka-Schista study protocol: a longitudinal cohort study and economic evaluation of an integrated home-based approach for genital multi-pathogen screening in women, including female genital schistosomiasis, HPV, Trichomonas and HIV in Zambia\nAuthors: Shanaube, K.; Ndubani, R.; Kelly, H.; Webb, E.; Mayaud, P.; Lamberti, O.; Fitzpatrick, J.; Kasese, N.; Sturt, A.; Van Lieshout, L.; Van Dam, G.; Corstjens, P. L. A. M.; Kosloff, B.; Bond, V.; Hayes, R.; Terris-Prestholt, F.; Webster, B.; Vwalika, B.; Hansingo, I.; Ayles, H.; Bustinduy, A. L.\nScore: 8.0, Published: 2023-10-03 DOI: 10.1101/2023.10.02.23296341\nIntroductionMultiplathogen home-based self-sampling offers an opportunity to increase access to screening and treatment. Infections include sexually transmitted (HIV, Trichomonas vaginalis (Tv), human papillomavirus [HPV] for cervical precancer detection) and non-sexually transmitted pathogens (Schistosoma haematobium (Sh)) pathogens, in endemic settings with high co-infection prevalence. Chronic infection may lead to disability (female genital schistosomiasis (FGS) and death (cervical cancer). The Zipime-Weka-Schista (Do self-testing sister!) aims to evaluate the validity, acceptability, uptake, impact and cost-effectiveness of multi-pathogen self-sampling for genital infections among women in Zambia. Methods and AnalysisThis is a longitudinal cohort study aiming to enrol 2,500 non-pregnant, sexually active and non-menstruating women aged 15-50 years from two districts in Zambia with two year follow up. During home visits, community health workers offer HIV and Tv self-testing and cervicovaginal self-swabs for (i) HPV by GeneXpert and, (ii) Sh DNA detection by conventional (PCR) and isothermal (RPA) molecular methods. Schistosoma ova and circulating anodic antigen are detected in urine. At a clinic follow-up midwifes perform same procedures and obtain hand-held colposcopic images. High-risk -HPV positive women are referred for a two-quadrant cervical biopsy according to age and HIV status. A cost-effectiveness analysis is conducted in parallel. Ethics and disseminationThe University of Zambia Biomedical Research Ethics Committee (UNZABREC) approved the study in September 2021 (reference: 1858-2021), the London School of Hygiene and Tropical Medicine(LSHTM) (reference: 25258) and Ministry of Health and local superintendents. Written informed consent was obtained from all participants prior to enrolment. Data will be available upon request on LSHTM Data Compass. Identifiable data collected is stored securely and their confidentiality protected in accordance with the Data Protection Act 1998. Strenghts and LimitationsO_LIFirst longitudinal cohort study of female genital schistosomiasis (FGS) C_LIO_LIHome package testing for validation and acceptability of self-sampling (FGS, HR-HPV) and self-testing (HIV and Trichomonas) C_LIO_LIFirst study addressing cost-effectiveness of community-based integration of FGS within the wider sexual and reproductive health screening in Zambia C_LIO_LIExisting sexually transmitted infection related stigma in the communities may difficult recruitment C_LIO_LILimited availability of histopathology laboratories may delay results C_LI\nInvestigating Racial Disparities in Drug Prescriptions for Patients with Endometriosis\nAuthors: Kashyap, A.; Aziz, M.; Sun, T. Y.; Lipsky-Gorman, S.; Opoku-Anane, J.; Elhadad, N.\nScore: 4.0, Published: 2023-10-03 DOI: 10.1101/2023.10.02.23296435\nBackgroundEndometriosis is a chronic disease with a long time to diagnosis and several known comorbidities that requires a range of treatments including of pain management and hormone-based medications. Racial disparities specific to endometriosis treatments are unknown. ObjectiveWe aim to investigate differences in patterns of drug prescriptions specific to endometriosis management in Black and White patients prior to diagnosis and after diagnosis of endometriosis and compare these differences to racial disparities established in the general population. Study DesignWe conduct a retrospective cohort study using observational health data from the IBM MarketScan(R) Multi-state Medicaid dataset. We identify a cohort of endometriosis patients consisting of women between the ages of 15 and 49 with an endometriosis-related surgical procedure and a diagnosis code for endometriosis within 30 days of this procedure. Cohort is further restricted to patients with at least 3 years of continuous observation prior to diagnosis. We identify a non-endometriosis cohort of women between the ages of 15 and 49 with no endometriosis diagnosis and at least 1 year of continuous observation. We compare prevalence of prescriptions across selected drug classes for Black vs. White endometriosis patients. We further examine prevalence differences in the non-endometriosis cohort and prevalence differences pre- and post-diagnosis in the endometriosis cohort. ResultsThe endometriosis cohort comprised 16,372 endometriosis patients (23.3% Black, 66.0% White). Of the 28 drug classes examined, 17 were prescribed significantly less in Black patients compared to 21 in non-endometriosis cohort (n=3,663,904), and 4 were prescribed significantly more in Black patients compared to 6 in the non-endometriosis cohort. Of the 17 drugs prescribed more often in White patients, 16 have larger disparities pre-diagnosis than post-diagnosis. ConclusionsOur analysis identified significant differences in medication prescriptions between White and Black patients with endometriosis, notably in hormonal treatments, pain management, and treatments for common endometriosis co-morbidities. Racial disparities in drug prescriptions are well established in healthcare, and better understanding these disparities in the specific context of chronic reproductive conditions and chronic pain is important for increasing equity in drug prescription practices.\n",
  "wordCount" : "782",
  "inLanguage": "en",
  "datePublished": "2023-10-11T10:39:46Z",
  "dateModified": "2023-10-11T10:39:46Z",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://trxiv.yorks0n.com/posts/sexual-and-reproductive-health/"
  },
  "publisher": {
    "@type": "Organization",
    "name": "TRxiv2",
    "logo": {
      "@type": "ImageObject",
      "url": "https://trxiv.yorks0n.com/favicon.ico"
    }
  }
}
</script>
</head>

<body class="" id="top">
<script>
    if (localStorage.getItem("pref-theme") === "dark") {
        document.body.classList.add('dark');
    } else if (localStorage.getItem("pref-theme") === "light") {
        document.body.classList.remove('dark')
    } else if (window.matchMedia('(prefers-color-scheme: dark)').matches) {
        document.body.classList.add('dark');
    }

</script>

<header class="header">
    <nav class="nav">
        <div class="logo">
            <a href="https://trxiv.yorks0n.com" accesskey="h" title="TRxiv2 (Alt + H)">TRxiv2</a>
            <div class="logo-switches">
                <button id="theme-toggle" accesskey="t" title="(Alt + T)">
                    <svg id="moon" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <path d="M21 12.79A9 9 0 1 1 11.21 3 7 7 0 0 0 21 12.79z"></path>
                    </svg>
                    <svg id="sun" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <circle cx="12" cy="12" r="5"></circle>
                        <line x1="12" y1="1" x2="12" y2="3"></line>
                        <line x1="12" y1="21" x2="12" y2="23"></line>
                        <line x1="4.22" y1="4.22" x2="5.64" y2="5.64"></line>
                        <line x1="18.36" y1="18.36" x2="19.78" y2="19.78"></line>
                        <line x1="1" y1="12" x2="3" y2="12"></line>
                        <line x1="21" y1="12" x2="23" y2="12"></line>
                        <line x1="4.22" y1="19.78" x2="5.64" y2="18.36"></line>
                        <line x1="18.36" y1="5.64" x2="19.78" y2="4.22"></line>
                    </svg>
                </button>
            </div>
        </div>
        <ul id="menu">
        </ul>
    </nav>
</header>
<main class="main">
<article class="post-single">
  <header class="post-header">
    
    <h1 class="post-title">
      sexual and reproductive health
    </h1>
    <div class="post-meta"><span>updated on October 11, 2023</span>

</div>
  </header> 
  <div class="post-content"><div class="accordion accordion-flush" id="accordionFlushExample"><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.10.02.23296341">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.10.02.23296341" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.10.02.23296341">
        <p class="paperTitle">The Zipime-Weka-Schista study protocol: a longitudinal cohort study and economic evaluation of an integrated home-based approach for genital multi-pathogen screening in women, including female genital schistosomiasis, HPV, Trichomonas and HIV in Zambia</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.10.02.23296341" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.10.02.23296341" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Shanaube, K.; Ndubani, R.; Kelly, H.; Webb, E.; Mayaud, P.; Lamberti, O.; Fitzpatrick, J.; Kasese, N.; Sturt, A.; Van Lieshout, L.; Van Dam, G.; Corstjens, P. L. A. M.; Kosloff, B.; Bond, V.; Hayes, R.; Terris-Prestholt, F.; Webster, B.; Vwalika, B.; Hansingo, I.; Ayles, H.; Bustinduy, A. L.</p>
        <p class="info">Score: 8.0, Published: 2023-10-03 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.10.02.23296341' target='https://doi.org/10.1101/2023.10.02.23296341'> 10.1101/2023.10.02.23296341</a></p>
        <p class="abstract">IntroductionMultiplathogen home-based self-sampling offers an opportunity to increase access to screening and treatment. Infections include sexually transmitted (HIV, Trichomonas vaginalis (Tv), human papillomavirus [HPV] for cervical precancer detection) and non-sexually transmitted pathogens (Schistosoma haematobium (Sh)) pathogens, in endemic settings with high co-infection prevalence. Chronic infection may lead to disability (female genital schistosomiasis (FGS) and death (cervical cancer). The Zipime-Weka-Schista (Do self-testing sister!) aims to evaluate the validity, acceptability, uptake, impact and cost-effectiveness of multi-pathogen self-sampling for genital infections among women in Zambia.

Methods and AnalysisThis is a longitudinal cohort study aiming to enrol 2,500 non-pregnant, sexually active and non-menstruating women aged 15-50 years from two districts in Zambia with two year follow up. During home visits, community health workers offer HIV and Tv self-testing and cervicovaginal self-swabs for (i) HPV by GeneXpert and, (ii) Sh DNA detection by conventional (PCR) and isothermal (RPA) molecular methods. Schistosoma ova and circulating anodic antigen are detected in urine. At a clinic follow-up midwifes perform same procedures and obtain hand-held colposcopic images. High-risk -HPV positive women are referred for a two-quadrant cervical biopsy according to age and HIV status. A cost-effectiveness analysis is conducted in parallel.

Ethics and disseminationThe University of Zambia Biomedical Research Ethics Committee (UNZABREC) approved the study in September 2021 (reference: 1858-2021), the London School of Hygiene and Tropical Medicine(LSHTM) (reference: 25258) and Ministry of Health and local superintendents. Written informed consent was obtained from all participants prior to enrolment. Data will be available upon request on LSHTM Data Compass. Identifiable data collected is stored securely and their confidentiality protected in accordance with the Data Protection Act 1998.

Strenghts and LimitationsO_LIFirst longitudinal cohort study of female genital schistosomiasis (FGS)
C_LIO_LIHome  package testing for validation and acceptability of self-sampling (FGS, HR-HPV) and self-testing (HIV and Trichomonas)
C_LIO_LIFirst study addressing cost-effectiveness of community-based integration of FGS within the wider sexual and reproductive health screening in Zambia
C_LIO_LIExisting sexually transmitted infection related stigma in the communities may difficult recruitment
C_LIO_LILimited availability of histopathology laboratories may delay results
C_LI</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.10.02.23296435">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.10.02.23296435" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.10.02.23296435">
        <p class="paperTitle">Investigating Racial Disparities in Drug Prescriptions for Patients with Endometriosis</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.10.02.23296435" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.10.02.23296435" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Kashyap, A.; Aziz, M.; Sun, T. Y.; Lipsky-Gorman, S.; Opoku-Anane, J.; Elhadad, N.</p>
        <p class="info">Score: 4.0, Published: 2023-10-03 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.10.02.23296435' target='https://doi.org/10.1101/2023.10.02.23296435'> 10.1101/2023.10.02.23296435</a></p>
        <p class="abstract">BackgroundEndometriosis is a chronic disease with a long time to diagnosis and several known comorbidities that requires a range of treatments including of pain management and hormone-based medications. Racial disparities specific to endometriosis treatments are unknown.

ObjectiveWe aim to investigate differences in patterns of drug prescriptions specific to endometriosis management in Black and White patients prior to diagnosis and after diagnosis of endometriosis and compare these differences to racial disparities established in the general population.

Study DesignWe conduct a retrospective cohort study using observational health data from the IBM MarketScan(R) Multi-state Medicaid dataset. We identify a cohort of endometriosis patients consisting of women between the ages of 15 and 49 with an endometriosis-related surgical procedure and a diagnosis code for endometriosis within 30 days of this procedure. Cohort is further restricted to patients with at least 3 years of continuous observation prior to diagnosis.

We identify a non-endometriosis cohort of women between the ages of 15 and 49 with no endometriosis diagnosis and at least 1 year of continuous observation. We compare prevalence of prescriptions across selected drug classes for Black vs. White endometriosis patients. We further examine prevalence differences in the non-endometriosis cohort and prevalence differences pre- and post-diagnosis in the endometriosis cohort.

ResultsThe endometriosis cohort comprised 16,372 endometriosis patients (23.3% Black, 66.0% White). Of the 28 drug classes examined, 17 were prescribed significantly less in Black patients compared to 21 in non-endometriosis cohort (n=3,663,904), and 4 were prescribed significantly more in Black patients compared to 6 in the non-endometriosis cohort. Of the 17 drugs prescribed more often in White patients, 16 have larger disparities pre-diagnosis than post-diagnosis.

ConclusionsOur analysis identified significant differences in medication prescriptions between White and Black patients with endometriosis, notably in hormonal treatments, pain management, and treatments for common endometriosis co-morbidities. Racial disparities in drug prescriptions are well established in healthcare, and better understanding these disparities in the specific context of chronic reproductive conditions and chronic pain is important for increasing equity in drug prescription practices.</p>
      </div>
    </div>
  </div>
</div>









<script src="/js/bundle.min.js" defer></script>



  </div>

  <footer class="post-footer">
    <ul class="post-tags">
    </ul>
  </footer>
</article>
    </main>
    
<footer class="footer">
    <span>&copy; 2023 <a href="https://trxiv.yorks0n.com">TRxiv2</a></span>
    <span>
        Â· Made by Yorkson
    </span>
</footer>
<a href="#top" aria-label="go to top" title="Go to Top (Alt + G)" class="top-link" id="top-link" accesskey="g">
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 12 6" fill="currentColor">
        <path d="M12 6H0l6-6z" />
    </svg>
</a>

<script>
    let menu = document.getElementById('menu')
    if (menu) {
        menu.scrollLeft = localStorage.getItem("menu-scroll-position");
        menu.onscroll = function () {
            localStorage.setItem("menu-scroll-position", menu.scrollLeft);
        }
    }

    document.querySelectorAll('a[href^="#"]').forEach(anchor => {
        anchor.addEventListener("click", function (e) {
            e.preventDefault();
            var id = this.getAttribute("href").substr(1);
            if (!window.matchMedia('(prefers-reduced-motion: reduce)').matches) {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView({
                    behavior: "smooth"
                });
            } else {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView();
            }
            if (id === "top") {
                history.replaceState(null, null, " ");
            } else {
                history.pushState(null, null, `#${id}`);
            }
        });
    });

</script>
<script>
    var mybutton = document.getElementById("top-link");
    window.onscroll = function () {
        if (document.body.scrollTop > 800 || document.documentElement.scrollTop > 800) {
            mybutton.style.visibility = "visible";
            mybutton.style.opacity = "1";
        } else {
            mybutton.style.visibility = "hidden";
            mybutton.style.opacity = "0";
        }
    };

</script>
<script>
    document.getElementById("theme-toggle").addEventListener("click", () => {
        if (document.body.className.includes("dark")) {
            document.body.classList.remove('dark');
            localStorage.setItem("pref-theme", 'light');
        } else {
            document.body.classList.add('dark');
            localStorage.setItem("pref-theme", 'dark');
        }
    })

</script>
</body>

</html>
